28077689|t|Giant cell arteritis and vascular disease-risk factors and outcomes: a cohort study using UK Clinical Practice Research Datalink
28077689|a|To evaluate the associations between GCA and vascular diseases and other comorbidities in patients with GCA compared with non-vasculitis patients. Using the UK-based Clinical Practice Research Datalink we identified 9778 newly diagnosed GCA patients in 1990-2014, and up to 10 non-vasculitis patients randomly matched to each case on age, sex, practice and years of history before cohort entry. We compared the distributions of 9 different pre-existing vascular diseases and 11 other comorbidities, and risks of incident vascular diseases and other comorbidities after cohort entry between GCA and non-vasculitis patients. Patients with GCA were more likely to have a history of vascular diseases and other comorbidities except myocardial infarction, type 2 diabetes, obesity and cancer, compared with non-vasculitis patients. Patients with GCA had increased risks for all types of incident vascular disease compared with non-vasculitis patients: adjusted hazard ratios were 1.57 (95% CI: 1.36, 1.82) for myocardial infarction, 1.41 (95% CI: 1.29, 1.55) for stroke, 1.75 (95% CI: 1.49, 2.06) for peripheral vascular disease, 1.98 (95% CI: 1.50, 2.62) for aortic aneurysm and 2.03 (95% CI: 1.77, 2.33) for venous thromboembolism. Patients with GCA also had increased risks for other incident comorbidities (type 2 diabetes, depression, etc.), but not for cancer. Patients with GCA had more prior vascular diseases and other comorbidities before the diagnosis and they also had increased risks for incident vascular diseases and many other incident comorbidities after the diagnosis compared with non-vasculitis population.
28077689	0	20	Giant cell arteritis	T047	C0039483
28077689	25	54	vascular disease-risk factors	T058	C2584745
28077689	59	67	outcomes	T062	C0543472
28077689	71	83	cohort study	T081	C0009247
28077689	90	92	UK	T083	C0041700
28077689	93	128	Clinical Practice Research Datalink	T170	C0282451
28077689	129	140	To evaluate	T058	C0220825
28077689	145	157	associations	T080	C0439849
28077689	166	169	GCA	T047	C0039483
28077689	174	191	vascular diseases	T047	C0042373
28077689	202	215	comorbidities	T078	C0009488
28077689	219	227	patients	T101	C0030705
28077689	233	236	GCA	T047	C0039483
28077689	251	274	non-vasculitis patients	T101	C0030705
28077689	286	294	UK-based	T083	C0041700
28077689	295	330	Clinical Practice Research Datalink	T170	C0282451
28077689	334	344	identified	T080	C0205396
28077689	350	365	newly diagnosed	T080	C1518321
28077689	366	369	GCA	T047	C0039483
28077689	370	378	patients	T101	C0030705
28077689	382	391	1990-2014	T079	C0585341
28077689	406	429	non-vasculitis patients	T101	C0030705
28077689	430	446	randomly matched	T062	C0034656
28077689	450	459	each case	T077	C1706256
28077689	463	466	age	T032	C0001779
28077689	468	471	sex	T032	C0079399
28077689	473	481	practice	T041	C0237607
28077689	486	502	years of history	T033	C2004062
28077689	503	509	before	T079	C0332152
28077689	510	522	cohort entry	T081	C0009247
28077689	527	535	compared	T052	C1707455
28077689	540	553	distributions	T169	C1704711
28077689	559	568	different	T080	C1705242
28077689	569	581	pre-existing	T080	C2347662
28077689	582	599	vascular diseases	T047	C0042373
28077689	613	626	comorbidities	T078	C0009488
28077689	632	649	risks of incident	T033	C1113667
28077689	650	667	vascular diseases	T047	C0042373
28077689	678	691	comorbidities	T078	C0009488
28077689	698	710	cohort entry	T081	C0009247
28077689	719	722	GCA	T047	C0039483
28077689	727	750	non-vasculitis patients	T101	C0030705
28077689	752	760	Patients	T101	C0030705
28077689	766	769	GCA	T047	C0039483
28077689	775	786	more likely	T080	C0205556
28077689	797	807	history of	T033	C0683519
28077689	808	825	vascular diseases	T047	C0042373
28077689	836	849	comorbidities	T078	C0009488
28077689	857	878	myocardial infarction	T047	C0027051
28077689	880	895	type 2 diabetes	T047	C0011860
28077689	897	904	obesity	T047	C0028754
28077689	909	915	cancer	T191	C0006826
28077689	917	925	compared	T052	C1707455
28077689	931	954	non-vasculitis patients	T101	C0030705
28077689	956	964	Patients	T101	C0030705
28077689	970	973	GCA	T047	C0039483
28077689	978	987	increased	T081	C0205217
28077689	988	1019	risks for all types of incident	T033	C0580320
28077689	1020	1036	vascular disease	T047	C0042373
28077689	1037	1045	compared	T052	C1707455
28077689	1051	1074	non-vasculitis patients	T101	C0030705
28077689	1076	1084	adjusted	T169	C0456081
28077689	1085	1098	hazard ratios	T081	C2985465
28077689	1114	1116	CI	T081	C0009667
28077689	1134	1155	myocardial infarction	T047	C0027051
28077689	1167	1169	CI	T081	C0009667
28077689	1187	1193	stroke	T047	C0038454
28077689	1205	1207	CI	T081	C0009667
28077689	1225	1252	peripheral vascular disease	T047	C0085096
28077689	1264	1266	CI	T081	C0009667
28077689	1284	1299	aortic aneurysm	T047	C0003486
28077689	1314	1316	CI	T081	C0009667
28077689	1334	1356	venous thromboembolism	T047	C1861172
28077689	1358	1366	Patients	T101	C0030705
28077689	1372	1375	GCA	T047	C0039483
28077689	1385	1394	increased	T081	C0205217
28077689	1395	1419	risks for other incident	T033	C1281905
28077689	1420	1433	comorbidities	T078	C0009488
28077689	1435	1450	type 2 diabetes	T047	C0011860
28077689	1452	1462	depression	T048	C0011570
28077689	1483	1489	cancer	T191	C0006826
28077689	1491	1499	Patients	T101	C0030705
28077689	1505	1508	GCA	T047	C0039483
28077689	1524	1541	vascular diseases	T047	C0042373
28077689	1552	1565	comorbidities	T078	C0009488
28077689	1566	1572	before	T079	C0332152
28077689	1577	1586	diagnosis	T033	C0011900
28077689	1605	1614	increased	T081	C0205217
28077689	1615	1633	risks for incident	T033	C1281905
28077689	1634	1651	vascular diseases	T047	C0042373
28077689	1667	1675	incident	T067	C1551358
28077689	1676	1689	comorbidities	T078	C0009488
28077689	1700	1709	diagnosis	T033	C0011900
28077689	1710	1718	compared	T052	C1707455
28077689	1724	1749	non-vasculitis population	T101	C0030705